Flex Raises Guidance As AI And Data Center Shift Reshapes Outlook

  • Flex highlighted strong demand in its data center and industrial segments in its latest Q4 update.
  • Management raised full year guidance, pointing to a focus on AI, automation, and higher value product offerings.
  • The company indicated a shift toward AI driven solutions and complex manufacturing for data center and industrial customers.

For investors watching NasdaqGS:FLEX, the latest update comes with the stock at about $62.6 and a very large 3 year return, suggesting the share price has already moved significantly over that period. The 1 year return of 47.7% and 7 day move of 4.1% frame this news against a backdrop of strong recent performance, even as the stock shows a 2.6% decline over 30 days and a 1.7% decline year to date. Taken together, this mix can make fresh company news more important for anyone reassessing their view.

Flex is leaning further into data center, AI related, and industrial automation work, which tend to involve more complex, higher value products. If management executes on this shift, the company’s earnings mix and sensitivity to different end markets could look quite different over time, something long term investors may want to track across future updates.

Stay updated on the most important news stories for Flex by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Flex.

NasdaqGS:FLEX Earnings & Revenue Growth as at Feb 2026
NasdaqGS:FLEX Earnings & Revenue Growth as at Feb 2026

4 things going right for Flex that this headline doesn't cover.

Advertisement

Quick Assessment

  • ⚖️ Price vs Analyst Target: At US$62.6 vs a consensus target of US$76.13, the shares sit about 18% below where analysts cluster within a relatively tight range.
  • ⚖️ Simply Wall St Valuation: Flex is described as trading close to estimated fair value, so the valuation signal is neither strongly cheap nor expensive.
  • ❌ Recent Momentum: The 30 day return of roughly 2.6% decline shows near term weakness despite the longer term gains.

There is only one way to know the right time to buy, sell or hold Flex. Head to the Simply Wall St company report for the latest analysis of Flex's Fair Value.

Key Considerations

  • 📊 Raised guidance linked to data center, AI and industrial demand suggests the business mix is tilting further toward higher value manufacturing work.
  • 📊 Watch how revenue, margins and P/E of 27.0 evolve against the industry average P/E of about 27.1 as new AI and automation programs ramp.
  • ⚠️ One flagged risk is significant insider selling over the past 3 months, which some investors treat as a caution signal.

Dig Deeper

For the full picture including more risks and rewards, check out the complete Flex analysis. Alternatively, you can check out the community page for Flex to see how other investors believe this latest news will impact the company's narrative.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqGS:FLEX

Flex

Provides technology innovation, supply chain, and manufacturing solutions to data center, communications, enterprise, consumer, automotive, healthcare, industrial, and power industries in the Americas, Asia, and Europe.

Exceptional growth potential with flawless balance sheet.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1157.5% undervalued
47 users have followed this narrative
2 users have commented on this narrative
7 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7721.4% undervalued
66 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9218.9% undervalued
22 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$19013.7% undervalued
24 users have followed this narrative
0 users have commented on this narrative
10 users have liked this narrative

Updated Narratives

WI
WisetoWealth
PYPL logo
WisetoWealth on PayPal Holdings ·

The Underrated Transformation of a Digital Payments Giant

Fair Value:US$90.3137.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BL
Blagget
TERA logo
Blagget on Terra Balcanica Resources ·

The C$4M Explorer Positioned to Become Europe's First Antimony Mine

Fair Value:CA$0.487.5% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DA
CHTR logo
david_6nroa on Charter Communications ·

Charter is undervalued - Here's why.

Fair Value:US$87.0741.6% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.919.1% undervalued
81 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28026.1% undervalued
185 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.6% undervalued
71 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0